Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors and other bioactive molecules targeting neurological disorders and cancer. Its structure allows for selective functionalization, making it valuable in medicinal chemistry for building complex heterocyclic systems. Commonly employed in coupling reactions to introduce the dihydroimidazopyrazine scaffold, which is known to enhance binding affinity and metabolic stability in drug candidates.